Please join Sidley’s Global Life Sciences team to lean into key early-stage and emerging growth regulatory issues, and how to tackle them.
If have questions or are interested in attending, please contact laevents@sidley.com.
Sessions will focus on:
- All phases of clinical research and development
- Press releases and disclosures
- Regulatory wisdom from experienced emerging growth General Counsels
Connect with industry peers and investors during networking breaks and a post-program cocktail hour.
This program is designed for legal professionals and executives to provide a foundation in FDA, healthcare, and securities issues arising in development stage companies.
Sidley Speakers
- Torey Cope, Food, Drug, and Medical Device Regulatory
- Meenakshi Datta, Healthcare: Drug and Medical Device Regulatory
- Carlton Fleming, Capital Markets
- Cindy Lovering, Global Finance
- James Lu, Emerging Companies and Venture Capital
- Jon Olsen, M&A, Emerging Companies and Venture Capital
- Adam Welland, Technology and Life Sciences Transactions
- Sharon Flanagan, M&A, Capital Markets, Corporate Governance
Agenda
1:00 p.m.: Registration
1:30 – 4:30 p.m.:
- Clinical Research Challenges and Opportunities
- Key Considerations for Press Releases and SEC Disclosures
- Fireside Chat: The Importance of Regulatory Strategy and Compliance from Seasoned Emerging Growth GCs
4:30 – 6:30 p.m.: Cocktail Reception
CLE credit for this program is pending.